Tele: 561.316.3330
Breaking Medical Device News

Saturday, October 16, 2021
HomeHOSPITALSPalm Beach Gardens Medical Center Offers Minimally Invasive Treatment Option for Heart...

Palm Beach Gardens Medical Center Offers Minimally Invasive Treatment Option for Heart Valve Patients

March 6, 2021

Palm Beach Gardens Medical Center is now offering patients new treatmentfor valve repair and replacement procedures.  

Palm Beach Gardens Medical Center is now able to perform minimally invasive surgery for several heart valve diseases.  Dr. Nishant Patel, cardiothoracic surgeon, is one of the first, and currently the only surgeon performing this procedure at the hospital.  

“These procedures are a breakthrough in our community, and we are looking forward to providing this level of care to our patients at Palm Beach Gardens Medical Center,” said Dr. Patel.  “Unlike traditional open heart surgery where the breast bone needs to be surgically separated, minimally invasive valve surgery is performed through a small incision between the ribs, which may offer less pain, scarring, and a faster return to your daily activities.

The following minimally procedures are now being offered at Palm Beach Gardens Medical Center:

Mitral Valve Repair and Replacement
Tricuspid Repair and Replacement
Aortic Valve Replacement
Ablation for Atrial Fibrillation
Atrial Septal Defect (ASD) Repair
Patent Foramen Ovale (PFO) Repair

“As one of the top heart hospitals in Palm Beach County, this is just another way we are able to bring some of the best cardiac care right here in our community,” said Teresa Urquhart, chief executive officer of Palm Beach Gardens Medical Center.“These new minimally invasive valve procedures will give people an easier recovery while being able to get back to their regular activities even quicker than before.  Our hospital has also taken the proper steps to continue providing safe and appropriate care to our patients.”  

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

Don't Miss

Ganymed Robotics Awarded a €2.5M Grant from the EC through the EIC Accelerator Program

Ganymed Robotics is developing a radically new approach to surgical robotics by combining computer vision, a branch of artificial intelligence, and mechatronics.

Global Healthcare Exchange Announces Acquisition of Explorer Surgical

Explorer Surgical will operate as a wholly-owned subsidiary of GHX.

Arlington Scientific Broadens Product Portfolio and Further Expands its Product Offering Through the acquisition of Non-Mammalian Blocking Buffers

Arlington Scientific, Inc. (ASI) is pleased to announce that it has acquired the non-mammalian blocking buffer product line from Clark McDermith, former owner of...

Laborie Medical Technologies Acquires Pelvalon

Laborie was represented by Piper Sandler (financial advisor) and Simpson Thacher & Bartlett LLP (legal advisor). Pelvalon was represented by J.P. Morgan Securities LLC (financial advisor) and Dorsey & Whitney LLP (legal advisor).

Herculite Products, Inc. Promotes Two Employees to New Roles

Paul Flaherty Chief Strategy Officer and Marco Angelone is being promoted to the role of Chief Financial Officer.

Prof. Joseph Kvedar Added to the Sweetch Advisory Board Member

Prof. Josdeph Kvedar is the current chair of the board at the American Telemedicine Association (ATA), formerly VP of Connected Health at Mass-Gen Brigham, co-chair of the American Medical Association (AMA) Digital Medicine Payment Advisory Group, and author of The Internet of Healthy Things and The New Mobile Age.

Sid Bala Named President of HealthChampion

Sid Bala is the former president and chief executive officer of alligatortek, a custom software applications company that was acquired by HealthChampion in 2020 where he led them for 27 years after he founded the business

Cochlear Announces FDA Approval and Clearance of first-of-its-kind Remote Care Capabilities for Nucleus and Baha Systems

The FDA approval for the cochlear implant solution and FDA clearance for the Baha solution is the first step in commercializing the product offering, anticipated spring 2022, and complement Cochlear's existing Remote Care offerings.

By using this website you agree to accept Medical Device News Magazine Privacy Policy